/ /

Cheryl Guttman Krader
Medical, surgical advances rising to challenge of persistent epithelial defects
Autologous serum drops, amniotic membrane, and scleral lenses offer advanced options for management of persistent epithelial defects refractory to standard treatment modalities.
Compounded topical corticosteroid-antibiotic combinations bring postLASIK benefits
Positive outcomes were achieved in a clinical evaluation of proprietary compounded topical corticosteroid-antibiotic combination products for treatment after LASIK.
Ophthalmologists’ role key to mitigating burden of diabetic eye disease
Preserving vision in patients with diabetes requires ophthalmologists to be aware of the importance of reinforcing preventive strategies, maintaining communication with internists/diabetologists, and keeping up to date with current treatment approaches.
SD-OCT useful tool for early detection of keratoconus
Spectral-domain optical coherence tomography is useful for diagnosing early keratoconus because it detects characteristic changes in epithelial and stromal thickness.
Adherence, persistence of glaucoma drug superior among prior latanoprost users
Adherence and persistence among patients prescribed bimatoprost 0.03% or bimatoprost 0.01% was investigated using pharmacy claims data, and the results showed statistically significant differences favoring bimatoprost 0.01%.
Glaucoma specialists focus attention on forthcoming advances, therapies
Specialists in glaucoma anticipate the future availability of a novel triple-action agent, as well as other medical and surgical management developments.
How femtosecond laser-assisted cataract surgery helps in challenging cases
Features of a proprietary femtosecond laser system enable successful laser-assisted cataract surgery in eyes with a history of LASIK or other pre-existing corneal conditions. The addition of intraoperative aberrometry optimizes IOL power selection.
Role of dexamethasone implant in DME characterized in study
Role of dexamethasone implant in DME characterized in study
A prospective, randomized trial of treatment for diabetic macular edema finds similar vision improvement with intravitreal bevacizumab (Avastin, Genentech) and an intravitreal dexamethasone implant (Ozurdex, Allergan), but differences in other endpoints.
Epiretinal prosthesis outcomes remain encouraging for retinitis pigmentosa
Outcomes remain positive after 12 to 36 months of follow-up in a series of 12 patients blind from retinitis pigmentosa who received a retinal prosthesis system.
Reading performance highlights functional impact of glaucoma
Reading speed is reduced in patients with glaucomatous visual field loss and normal visual acuity, and the reduction in performance is directly proportional to the extent of the visual field loss, said Aron Guimaraes, MD.

Poll

View Results